Nautilus Biotechnology Income Statement (2020-2026) | NAUT

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
6.38M8.24M9.89M9.66M8.86M9.57M9.59M10.88M11.91M12.00M12.47M12.93M12.44M12.29M12.82M11.54M10.39M9.61M9.57M9.71M
Selling, General & Administrative (Quarter)
4.32M6.32M6.92M6.36M6.62M6.25M6.72M7.18M7.10M7.08M7.54M8.68M8.35M6.81M7.16M7.31M6.70M5.87M5.85M6.42M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
10.70M14.57M16.82M16.02M15.47M15.82M16.30M18.06M19.02M19.07M20.00M21.61M20.79M19.10M19.98M18.84M17.10M15.47M15.42M16.12M
Operating Income (Quarter)
EBIT (Quarter)
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.14M0.16M0.26M0.78M1.89M2.89M3.10M3.22M3.20M3.03M2.88M2.80M2.67M2.43M2.23M2.08M1.90M1.65M1.44M
Other Non Operating Income (Quarter)
-0.07M0.01M-0.13M-0.01M
Non Operating Income (Quarter)
-0.02M-0.07M0.13M0.26M0.01M-0.13M2.90M3.10M3.21M3.20M2.98M2.88M2.78M2.65M2.39M2.23M2.06M1.90M1.64M1.43M
Net income details
EBT (Quarter)
Profit After Tax (Quarter)
-10.71M-14.50M-16.69M-15.76M-14.69M-14.06M-13.41M-14.96M-15.81M-15.88M-17.02M-18.73M-18.01M-16.45M-17.59M-16.61M-15.03M-13.57M-13.78M-14.70M
Income from Continuing Operations (Quarter)
Consolidated Net Income (Quarter)
Income towards Parent Company (Quarter)
Net Income towards Common Stockholders (Quarter)
Additional items
EPS (Basic) (Quarter)
-0.19-0.12-0.13-0.13-0.12-0.11-0.10-0.12-0.13-0.13-0.14-0.15-0.14-0.13-0.14-0.13-0.12-0.11-0.11-0.12
EPS (Weighted Average and Diluted) (Quarter)
-0.19-0.12-0.13-0.13-0.12-0.11-0.10-0.12-0.13-0.13-0.14-0.15-0.14-0.13-0.14-0.13-0.12-0.11-0.11-0.12
Shares Outstanding (Weighted Average) (Quarter)
44.10M124.11M84.46M124.42M124.46M124.52M124.59M124.59M124.60M124.90M124.92M125.14M125.23M125.30M125.43M126.14M126.17M126.31M126.26M126.63M
Shares Outstanding (Diluted Average) (Quarter)
44.10M124.11M84.46M124.42M124.49M124.52M124.59M124.59M124.60M124.93M124.92M125.14M125.32M125.45M125.43M126.14M126.17M126.22M126.26M126.63M
EBITDA (Quarter)
-10.72M-14.50M-16.86M-16.13M-14.90M-15.18M-17.24M-15.52M-19.22M-16.48M
Interest Expenses (Quarter)
0.01M0.00M0.01M0.06M0.02M0.02M0.04M0.02M0.01M0.01M0.01M